When your financial partner understands your business as well as you do, progress is inevitable.
Pharmaceuticals
India is the largest global supplier of generic drugs and is known for affordable vaccines and generic medications. The Indian pharmaceutical industry is ranked third in the world in terms of pharmaceutical production by volume. Major segments include generic drugs, over-the-counter medications, bulk drugs, vaccines, contract research & manufacturing, biosimilars, and biologics. The sector is also advancing healthcare globally through R&D and innovation, with key product segments such as novel drug formulations, oncological medications, and modified-release formulations.
Customers across
the country
the country
0
+
Cumulative Disbursal
in Rs.Crs
in Rs.Crs
0
+
Locations
0
India’s pharmaceutical industry has several competitive advantages
- High-quality, low-cost medicine production
- Low production and R&D costs, driving efficient exports
- Collaborations and alliances with global companies to share best practices and improve operational efficiency
- Growing private sector investments in R&D and acquisitions, fuelling sector growth
Key Growth Drivers of the Pharmaceutical Industry
- Rising lifestyle diseases increasing demand for medications
- Improved drug accessibility and growing health insurance penetration
- Enhanced diagnostic facilities supporting disease prevention and treatment
India is a major global supplier of affordable generic medicines, with a significant number of plants adhering to WHO and USFDA standards. With ongoing government support, including the National Health Protection Scheme, the industry is poised for further growth. The rise of chronic diseases like cardiovascular conditions, diabetes, depression, and cancer will increase demand for therapeutic drugs. Moreover, the push for generic drug introductions and rural health programs will also contribute to industry growth.
Profectus Capital provides tailored financial solutions to MSMEs in the pharmaceutical sector, addressing their unique needs, such as funding for expansion, machinery purchase, and setting up new manufacturing units. Our financing helps pharmaceutical MSMEs meet their capital requirements, drive business growth, and contribute to healthcare advancements.
Profectus Capital provides tailored financial solutions to MSMEs in the pharmaceutical sector, addressing their unique needs, such as funding for expansion, machinery purchase, and setting up new manufacturing units. Our financing helps pharmaceutical MSMEs meet their capital requirements, drive business growth, and contribute to healthcare advancements.
What Profectus Capital offers to the Pharmaceuticals Sector
Comprehensive loan options
Term loans, working capital loans, and equipment loans for pharmaceutical business requirements
Tailored for
pharmaceutical businesses
Specialized funding for bulk drugs, formulations, generics, and related sectors
Funding scope
Equipment loans up to Rs. 3 crore without the need for secondary collateral
Flexible eligibility criteria
Assessments based on cash flow and equipment viability for smoother approval processes
Some of the Machineries we Fund
Profectus Capital supports MSMEs in the pharmaceuticals industry with financing for a broad range of machinery, including:
-
High-Performance Liquid Chromatography (HPLC) Systems
-
Reactors (Glass Lined)
-
Centrifuge Machines
-
Blenders and Dryer Trays
-
Rotary Tablet Press Machines
-
Capsule Filling Machines
-
Rapid Mixer Granulators
-
Fluid Bed Dryers
-
Tablet Coating Machines
-
Granulation Equipment
-
Compression Machines
-
Sterilizing Equipment
-
Liquid Filling Machines
-
Packing Machines
-
Conveying Systems
Enquiry Form
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed
